GlassScriptPhysician profile
Simha Vivek Jagadeesh
NPI 1639337272
$67,349.39
in general payments reported to CMS, 2019-2025
52 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $3,132 · 2021: $8,390 · 2022: $5,172 · 2023: $11K · 2024: $7,055 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $5,148 · Food and Beverage: $4,775 · Consulting Fee: $4,100 · Education: $3,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,600.00 |
| Travel and Lodging | $5,147.74 |
| Food and Beverage | $4,774.74 |
| Consulting Fee | $4,100.00 |
| Education | $3,212.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $52,346.11 | 2019-2025 | Ofev |
| Intuitive Surgical, INC. | $5,931.10 | 2022-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,582.58 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,350.39 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Actelion Pharmaceuticals US, INC. | $1,330.35 | 2019-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $441.91 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $362.26 | 2019-2024 | Dupixent |
| Insmed, INC. | $297.39 | 2019-2024 | Arikayce |
| United Therapeutics Corporation | $270.27 | 2019-2024 | Tyvaso, Orenitram |
| Grifols USA, LLC | $214.03 | 2019-2025 | Prolastin-C Liquid |
| Amgen INC. | $209.77 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $208.59 | 2025 | Ohtuvayre |
| Pfizer INC. | $208.01 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $182.44 | 2022-2025 | Glassia |
| Inari Medical, INC. | $180.58 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $177.71 | 2019-2021 | |
| Baxter Healthcare | $123.34 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Viatris Specialty LLC | $114.65 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $113.20 | 2019-2025 | Keytruda |
| Alexion Pharmaceuticals, INC. | $111.88 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $104.81 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $93.73 | 2019-2020 | |
| Electromed, INC. | $90.13 | 2019-2024 | Smartvest |
| Bioxcel Therapeutics, INC. | $85.53 | 2023 | Igalmi |
| Bayer Healthcare Pharmaceuticals INC. | $85.00 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $83.76 | 2022-2024 | Acthar |
| Genzyme Corporation | $80.36 | 2019-2024 | |
| La Jolla Pharmaceutical Company | $74.75 | 2019-2025 | Giapreza |
| Edwards Lifesciences Corporation | $68.28 | 2019 | |
| Ani Pharmaceuticals, INC. | $64.81 | 2023 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $63.55 | 2019 | |
| Inspire Medical Systems, INC. | $63.53 | 2024-2025 | Inspire |
| Abbvie INC. | $63.02 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $57.87 | 2022-2023 | Airduo Digihaler |
| Janssen Pharmaceuticals, INC | $54.47 | 2019-2021 | |
| Gilead Sciences, INC. | $48.98 | 2021-2022 | |
| Tactile Systems Technology INC | $48.60 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Axsome Therapeutics, INC. | $46.48 | 2022-2023 | Sunosi |
| Philips North America LLC | $40.04 | 2022-2025 | Vest Therapy Und |
| Sunovion Pharmaceuticals INC. | $39.12 | 2019-2020 | |
| Resmed Corp | $30.18 | 2022 | |
| Abiomed | $29.15 | 2024 | |
| Vifor Pharma, INC. | $28.77 | 2025 | Zemaira |
| Baudax Bio INC. | $20.90 | 2021 | |
| Pulmonx Corporation | $19.97 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Shire North American Group INC | $19.40 | 2019 | |
| Harmony Biosciences LLC | $19.20 | 2023 | Wakix |
| Genentech USA, INC. | $18.18 | 2019 | |
| Eisai INC. | $16.27 | 2021 | |
| Chiesi USA, INC. | $13.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.44 | 2021 | |
| Veran Medical Technologies, INC. | $9.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simha Jagadeesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.